DIN 02536994 — PMS-METHYLPHENIDATE CR 40 MG
PMS-METHYLPHENIDATE CR is a capsule (extended-release) of Methylphenidate marketed by PHARMASCIENCE INC. The full Methylphenidate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02536994
- Brand name
- PMS-METHYLPHENIDATE CR
- Active ingredient
- Methylphenidate
- Strength
- 40 MG
- Dosage form
- CAPSULE (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- PHARMASCIENCE INC
- Health Canada status
- MARKETED
- Drug class
- CNS stimulant (norepinephrine-dopamine reuptake inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Methylphenidate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02266687 | AA-METHYLPHENIDATE SR | 20 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED |
| 02441934 | ACT METHYLPHENIDATE ER | 18 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02441942 | ACT METHYLPHENIDATE ER | 27 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02441950 | ACT METHYLPHENIDATE ER | 36 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02441969 | ACT METHYLPHENIDATE ER | 54 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02249324 | APO-METHYLPHENIDATE | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02249332 | APO-METHYLPHENIDATE | 20 MG | TABLET | APOTEX INC | MARKETED |
| 02273950 | APO-METHYLPHENIDATE | 5 MG | TABLET | APOTEX INC | MARKETED |
| 02452731 | APO-METHYLPHENIDATE ER | 18 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02452758 | APO-METHYLPHENIDATE ER | 27 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02452766 | APO-METHYLPHENIDATE ER | 36 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02330377 | APO-METHYLPHENIDATE ER | 54 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02277166 | BIPHENTIN | 10 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277131 | BIPHENTIN | 15 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277158 | BIPHENTIN | 20 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277174 | BIPHENTIN | 30 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277182 | BIPHENTIN | 40 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277190 | BIPHENTIN | 50 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277204 | BIPHENTIN | 60 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02277212 | BIPHENTIN | 80 MG | CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02247732 | CONCERTA | 18 MG | TABLET (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02250241 | CONCERTA | 27 MG | TABLET (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02247733 | CONCERTA | 36 MG | TABLET (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02247734 | CONCERTA | 54 MG | TABLET (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02470357 | FOQUEST | 100 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470292 | FOQUEST | 25 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470306 | FOQUEST | 35 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470314 | FOQUEST | 45 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470322 | FOQUEST | 55 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470330 | FOQUEST | 70 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02470349 | FOQUEST | 85 MG | CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | MARKETED |
| 02553023 | JORNAY PM | 100 MG | CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02553074 | JORNAY PM | 20 MG | CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02553066 | JORNAY PM | 40 MG | CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02553058 | JORNAY PM | 60 MG | CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02553031 | JORNAY PM | 80 MG | CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 00584991 | PMS-METHYLPHENIDATE | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00585009 | PMS-METHYLPHENIDATE | 20 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02234749 | PMS-METHYLPHENIDATE | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02536943 | PMS-METHYLPHENIDATE CR | 10 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02536951 | PMS-METHYLPHENIDATE CR | 15 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02536978 | PMS-METHYLPHENIDATE CR | 20 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02536986 | PMS-METHYLPHENIDATE CR | 30 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02537001 | PMS-METHYLPHENIDATE CR | 50 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02537028 | PMS-METHYLPHENIDATE CR | 60 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02537036 | PMS-METHYLPHENIDATE CR | 80 MG | CAPSULE (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02541602 | QUILLIVANT ER CHEWABLE TABLETS | 20 MG | TABLET (CHEWABLE EXTENDED-RELEASE) | KYE PHARMACEUTICALS INC. | MARKETED |
| 02541610 | QUILLIVANT ER CHEWABLE TABLETS | 30 MG | TABLET (CHEWABLE EXTENDED-RELEASE) | KYE PHARMACEUTICALS INC. | MARKETED |
| 02541629 | QUILLIVANT ER CHEWABLE TABLETS | 40 MG | TABLET (CHEWABLE EXTENDED-RELEASE) | KYE PHARMACEUTICALS INC. | MARKETED |
| 02541637 | QUILLIVANT ER ORAL SUSPENSION | 5 MG | POWDER (EXTENDED-RELEASE) | KYE PHARMACEUTICALS INC. | MARKETED |
| 02539004 | TARO-METHYLPHENIDATE ER | 18 MG | TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | MARKETED |
| 02539012 | TARO-METHYLPHENIDATE ER | 27 MG | TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | MARKETED |
| 02539020 | TARO-METHYLPHENIDATE ER | 36 MG | TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | MARKETED |
| 02539039 | TARO-METHYLPHENIDATE ER | 54 MG | TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | MARKETED |